[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

SELB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 31.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $42,262.79

Selecta Biosciences Insider Trading History Chart

Selecta Biosciences Share Price & Price History

^$0.00

+0.30 (1.20%)

As of 11/13/2023 05:00 PM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

Selecta Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/25/2023	Carsten Brunn	CEO	Sell	2,932	$1.06	$3,107.92	783,081
9/25/2023	Peter G. Traber	Insider	Sell	705	$1.06	$747.30	451,826
1/4/2023	Carsten Brunn	CEO	Sell	27,597	$1.13	$31,184.61	799,486
1/4/2023	Lloyd P Johnston	Insider	Sell	6,392	$1.13	$7,222.96	268,907
12/5/2022	Carsten Brunn	CEO	Sell	4,522	$1.33	$6,014.26	544,283
9/28/2022	Carsten Brunn	CEO	Sell	2,692	$1.66	$4,468.72	537,867
6/13/2022	Carrie Smith Cox	Director	Buy	130,000	$1.15	$149,500.00	212,881
5/9/2022	Timothy C Barabe	Director	Buy	50,000	$0.77	$38,500.00	250,013
1/5/2022	Carsten Brunn	CEO	Sell	13,597	$3.09	$42,014.73
1/5/2022	Peter G. Traber	Insider	Sell	3,226	$3.09	$9,968.34
12/15/2021	Timothy A. Springer	Director	Buy	211,190	$2.99	$631,458.10
12/13/2021	Timothy A. Springer	Director	Buy	14,592	$2.98	$43,484.16
12/10/2021	Carsten Brunn	CEO	Sell	17,196	$2.99	$51,416.04
12/10/2021	Peter G. Traber	Insider	Sell	4,083	$2.99	$12,208.17
12/9/2021	Timothy A. Springer	Director	Buy	3,748,000	$3.06	$11,468,880.00
12/2/2021	Carsten Brunn	CEO	Sell	4,746	$2.96	$14,048.16
12/2/2021	Kevin Tan	CFO	Buy	5,000	$3.03	$15,150.00
12/2/2021	Nishan M. de Silva	Director	Buy	7,000	$2.96	$20,720.00
10/13/2021	Carsten Brunn	CEO	Sell	15,313	$4.39	$67,224.07
10/13/2021	Peter G. Traber	Insider	Sell	3,636	$4.39	$15,962.04
8/18/2021	Timothy C. Barabe	Director	Buy	9,000	$4.00	$36,000.00	190,013
5/26/2021	Peter G. Traber	Insider	Buy	20,000	$3.99	$79,800.00	135,500
5/24/2021	Peter G. Traber	Insider	Buy	12,500	$3.32	$41,500.00	110,500
3/26/2021	Timothy C Barabe	Director	Buy	10,000	$4.10	$41,000.00	181,013
3/17/2021	Lloyd P Johnston	COO	Sell	15,128	$4.45	$67,319.60	87,477
3/17/2021	Peter G. Traber	Insider	Buy	10,000	$4.53	$45,300.00	88,000
12/14/2020	Peter G. Traber	Insider	Buy	40,000	$3.24	$129,600.00	40,000

Trading Experts Call It “The Perfect Tesla Trade”

From Wealthpress | Ad

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

Click here for details,

SEC Filings (Institutional Ownership Changes) for Selecta Biosciences (NASDAQ:SELB)

41.95% of Selecta Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Selecta Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2023	California State Teachers Retirement System	25,627	$27K	0.0%	-33.7%	0.017%
11/13/2023	Personal CFO Solutions LLC	54,888	$58K	0.0%	-35.3%	0.035%
11/13/2023	Northern Trust Corp	947,334	$1M	0.0%	+1.5%	0.610%
11/9/2023	Deutsche Bank AG	65,815	$70K	0.0%	N/A	0.042%
11/7/2023	New York State Common Retirement Fund	45,266	$48K	0.0%	-46.6%	0.029%
10/27/2023	Allspring Global Investments Holdings LLC	47,895	$51K	0.0%	N/A	0.031%
10/24/2023	Bank of New York Mellon Corp	590,984	$0.63M	0.0%	+1.9%	0.385%
10/13/2023	SG Americas Securities LLC	41,938	$44K	0.0%	N/A	0.027%
9/21/2023	Barclays PLC	61,240	$69K	0.0%	+61.2%	0.040%
8/21/2023	California State Teachers Retirement System	38,635	$43K	0.0%	N/A	0.025%
8/16/2023	Nuveen Asset Management LLC	672,740	$0.75M	0.0%	N/A	0.438%
8/15/2023	Alliancebernstein L.P.	22,720	$25K	0.0%	N/A	0.015%
8/15/2023	Wells Fargo & Company MN	45,909	$51K	0.0%	+3,253.5%	0.030%
8/15/2023	XTX Topco Ltd	148,242	$0.17M	0.0%	N/A	0.097%
8/15/2023	Goldman Sachs Group Inc.	1,410,878	$1.58M	0.0%	+265.8%	0.920%
8/15/2023	Royal Bank of Canada	86,499	$97K	0.0%	+14.0%	0.056%
8/15/2023	Sphera Funds Management LTD.	2,038,500	$2.28M	0.4%	-12.3%	1.329%
8/14/2023	Two Sigma Securities LLC	27,477	$31K	0.0%	+61.2%	0.018%
8/14/2023	State Street Corp	1,965,211	$2.20M	0.0%	+366.0%	1.281%
8/14/2023	Nuveen Asset Management LLC	672,740	$0.75M	0.0%	N/A	0.438%
8/11/2023	Renaissance Technologies LLC	1,002,502	$1.12M	0.0%	-6.6%	0.653%
8/11/2023	BlackRock Inc.	7,881,105	$8.83M	0.0%	+227.3%	5.137%
8/11/2023	Geode Capital Management LLC	2,367,278	$2.65M	0.0%	+95.0%	1.543%
8/11/2023	Artal Group S.A.	9,136,635	$10.23M	0.3%	+87.1%	5.955%
8/11/2023	JPMorgan Chase & Co.	2,046,844	$2.29M	0.0%	+2.5%	1.334%
8/11/2023	Northern Trust Corp	933,221	$1.05M	0.0%	+347.7%	0.608%
8/10/2023	MetLife Investment Management LLC	62,179	$70K	0.0%	N/A	0.041%
8/10/2023	ProShare Advisors LLC	25,032	$28K	0.0%	+136.0%	0.016%
8/10/2023	Charles Schwab Investment Management Inc.	325,308	$0.36M	0.0%	+444.0%	0.212%
8/10/2023	Citigroup Inc.	37,187	$42K	0.0%	-80.5%	0.024%
8/9/2023	BNP Paribas Arbitrage SNC	30,323	$34K	0.0%	+2,283.9%	0.020%
8/4/2023	American International Group Inc.	55,902	$63K	0.0%	N/A	0.036%
8/4/2023	CM Management LLC	700,000	$0.78M	0.8%	+16.7%	0.456%
8/3/2023	Barclays PLC	61,240	$69K	0.0%	+61.2%	0.040%
8/3/2023	Mackenzie Financial Corp	27,689	$31K	0.0%	+74.2%	0.018%
8/3/2023	Bank of New York Mellon Corp	579,754	$0.65M	0.0%	+99.0%	0.378%
7/27/2023	Virtu Financial LLC	55,759	$62K	0.0%	N/A	0.036%
5/22/2023	Ameriprise Financial Inc.	388,822	$0.54M	0.0%	+39.5%	0.253%
5/18/2023	JPMorgan Chase & Co.	1,996,092	$2.77M	0.0%	-1.3%	1.301%
5/16/2023	Susquehanna International Group LLP	841,071	$1.17M	0.0%	+3,967.1%	0.548%
5/16/2023	Jane Street Group LLC	180,038	$0.25M	0.0%	N/A	0.117%
5/16/2023	Sphera Funds Management LTD.	2,325,000	$3.23M	0.5%	N/A	1.515%
5/16/2023	Squarepoint Ops LLC	110,934	$0.15M	0.0%	N/A	0.072%
5/16/2023	First Trust Advisors LP	305,567	$0.43M	0.0%	+8.3%	0.199%
5/16/2023	Geode Capital Management LLC	1,213,828	$1.69M	0.0%	+3.3%	0.791%
5/16/2023	Balyasny Asset Management L.P.	48,936	$68K	0.0%	+136.2%	0.032%
5/16/2023	BlueCrest Capital Management Ltd	330,292	$0.46M	0.0%	N/A	0.215%
5/15/2023	Cubist Systematic Strategies LLC	18,276	$25K	0.0%	N/A	0.012%
5/15/2023	Ironwood Investment Management LLC	188,862	$0.26M	0.2%	+6.6%	0.123%
5/15/2023	EcoR1 Capital LLC	200,000	$0.28M	0.0%	-94.3%	0.130%
5/15/2023	Two Sigma Advisers LP	440,600	$0.61M	0.0%	-26.9%	0.287%
5/15/2023	Two Sigma Investments LP	201,323	$0.28M	0.0%	-36.6%	0.131%
5/15/2023	Healthcare of Ontario Pension Plan Trust Fund	28,800	$40K	0.0%	-96.0%	0.019%
5/12/2023	Renaissance Technologies LLC	1,073,087	$1.49M	0.0%	-12.4%	0.699%
5/12/2023	BlackRock Inc.	2,408,113	$3.35M	0.0%	-2.2%	1.570%
5/12/2023	Bank of America Corp DE	97,765	$0.14M	0.0%	+98.8%	0.064%
5/12/2023	Mirabella Financial Services LLP	145,423	$4.03M	0.6%	+317.0%	0.095%
5/12/2023	HRT Financial LP	382,971	$0.53M	0.0%	N/A	0.250%
5/11/2023	Acadian Asset Management LLC	1,509,229	$2.10M	0.0%	-9.6%	0.984%
5/11/2023	FMR LLC	703,035	$0.98M	0.0%	+31.3%	0.458%
5/11/2023	ExodusPoint Capital Management LP	24,000	$33K	0.0%	N/A	0.016%
5/11/2023	Citigroup Inc.	190,871	$0.27M	0.0%	-37.1%	0.124%
5/9/2023	Tower Research Capital LLC TRC	22,451	$31K	0.0%	-50.4%	0.015%
5/9/2023	Bank of New York Mellon Corp	291,293	$0.41M	0.0%	-19.3%	0.190%
5/3/2023	Jump Financial LLC	91,600	$0.13M	0.0%	N/A	0.060%
4/27/2023	Simplex Trading LLC	35,158	$48K	0.0%	N/A	0.023%
4/26/2023	James Investment Research Inc.	35,520	$49K	0.0%	N/A	0.023%
2/16/2023	State of Wyoming	50,340	$57K	0.0%	+282.5%	0.033%
2/15/2023	Lazard Asset Management LLC	56,956	$63K	0.0%	+17.8%	0.037%
2/15/2023	Millennium Management LLC	1,652,914	$1.87M	0.0%	-65.9%	1.080%
2/15/2023	Morgan Stanley	143,387	$0.16M	0.0%	+56.8%	0.094%
2/15/2023	Man Group plc	156,183	$0.18M	0.0%	+14.7%	0.102%
2/15/2023	Endurant Capital Management LP	3,777,618	$4.27M	1.7%	-4.1%	2.469%
2/14/2023	Marshall Wace LLP	1,310,443	$1.48M	0.0%	-29.1%	0.856%
2/14/2023	Two Sigma Investments LP	317,508	$0.36M	0.0%	-61.9%	0.207%
2/13/2023	Renaissance Technologies LLC	1,224,855	$1.38M	0.0%	+35.3%	0.800%
2/13/2023	Geode Capital Management LLC	1,174,773	$1.33M	0.0%	-3.1%	0.768%
2/13/2023	GSA Capital Partners LLP	372,087	$0.42M	0.1%	-48.7%	0.243%
2/13/2023	JPMorgan Chase & Co.	2,021,428	$2.29M	0.0%	-0.3%	1.321%
2/10/2023	Bank of America Corp DE	49,180	$56K	0.0%	-38.4%	0.032%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	27,239	$31K	0.0%	-81.5%	0.018%
2/9/2023	First Trust Advisors LP	282,265	$0.32M	0.0%	-6.3%	0.184%
2/9/2023	Dimensional Fund Advisors LP	53,850	$61K	0.0%	-61.4%	0.035%
2/9/2023	Citigroup Inc.	303,660	$0.34M	0.0%	+2,090.3%	0.198%
2/1/2023	Bank of Montreal Can	232,300	$0.26M	0.0%	-78.0%	0.152%
1/31/2023	Ironwood Investment Management LLC	177,182	$0.20M	0.1%	-11.0%	0.116%
12/8/2022	Bank of New York Mellon Corp	73,974	$0.12M	0.0%	+97.2%	0.048%
11/15/2022	State Street Corp	424,198	$0.70M	0.0%	+10.0%	0.277%
11/15/2022	Jacobs Levy Equity Management Inc.	721,019	$1.18M	0.0%	-22.6%	0.471%
11/15/2022	Two Sigma Advisers LP	886,900	$1.46M	0.0%	+21.1%	0.580%
11/15/2022	Two Sigma Investments LP	833,043	$1.37M	0.0%	+551.2%	0.544%
11/15/2022	Vanguard Group Inc.	6,146,460	$10.08M	0.0%	+11.1%	4.016%
11/15/2022	Mangrove Partners	5,260,419	$8.63M	0.5%	-27.5%	3.438%
11/15/2022	Marshall Wace LLP	1,849,070	$3.03M	0.0%	+88.2%	1.208%
11/15/2022	Endurant Capital Management LP	3,938,409	$6.46M	2.1%	-14.6%	2.574%
11/15/2022	Engineers Gate Manager LP	19,066	$31K	0.0%	-70.3%	0.012%
11/15/2022	First Trust Advisors LP	301,253	$0.49M	0.0%	N/A	0.197%
11/15/2022	BVF Inc. IL	1,391,749	$2.28M	0.1%	-19.2%	0.909%
11/15/2022	Bank of New York Mellon Corp	73,974	$0.12M	0.0%	+97.2%	0.048%
11/15/2022	Bayesian Capital Management LP	44,274	$73K	0.0%	N/A	0.029%

Data available starting January 2016

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in Phase I clinical trial to enhance the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout; and product candidates to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and Henoch-Schonlein purpura. In addition, the company is developing gene therapies comprising for the treatment of pompe disease, duchenne muscular dystrophy, limb-girdle muscular dystrophy, lysosomal storage disorder, and other autoimmune diseases. Further, it develops tolerogenic therapies to treat autoimmune diseases. The company has license and collaboration agreements with Ginkgo Bioworks Holdings, Inc.; Genovis AB (publ.); Cyrus Biotechnology, Inc.; IGAN Biosciences, Inc.; Astellas Therapeutics, Inc.; Takeda Pharmaceuticals USA, Inc.; Swedish Orphan Biovitrum AB (publ.); Sarepta Therapeutics, Inc.; Asklepios Biopharmaceutical, Inc.; Massachusetts Institute of Technology; and Shenyang Sunshine Pharmaceutical Co., Ltd. Selecta Biosciences, Inc. was incorporated in 2007 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: N/A

50 Day Range

MA: $1.08

$0.88

$1.26

52 Week Range

Now: N/A

Volume

2,774,100 shs

Average Volume

979,585 shs

Market Capitalization

$136.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Who are the company insiders with the largest holdings of Selecta Biosciences?: Selecta Biosciences' top insider investors include:
Carsten Brunn (CEO)
Peter G Traber (Insider)
Lloyd P Johnston (Insider)
Timothy C Barabe (Director)
Carrie Smith Cox (Director)
Timothy A Springer (Director)
Learn More about top insider investors at Selecta Biosciences.
Who are the major institutional investors of Selecta Biosciences?: Selecta Biosciences' top institutional shareholders include:
Northern Trust Corp — 0.61%
Bank of New York Mellon Corp — 0.39%
Deutsche Bank AG — 0.04%
Personal CFO Solutions LLC — 0.04%
Allspring Global Investments Holdings LLC — 0.03%
New York State Common Retirement Fund — 0.03%
Learn More about top institutional investors of Selecta Biosciences stock.
Which major investors are selling Selecta Biosciences stock?: During the last quarter, SELB stock was sold by these institutional investors:
New York State Common Retirement Fund
Personal CFO Solutions LLC
California State Teachers Retirement System
Within the last year, company insiders that have sold Selecta Biosciences company stock include:
Carsten Brunn (CEO)
Peter G Traber (Insider)
Lloyd P Johnston (Insider)
Learn More investors selling Selecta Biosciences stock.
Which major investors are buying Selecta Biosciences stock?: During the last quarter, SELB stock was acquired by institutional investors including:
Deutsche Bank AG
Allspring Global Investments Holdings LLC
SG Americas Securities LLC
Northern Trust Corp
Bank of New York Mellon Corp
Group One Trading L.P.
In the previous year, these company insiders have bought Selecta Biosciences stock:
Carsten Brunn (CEO)
Peter G Traber (Insider)
Lloyd P Johnston (Insider)
Learn More investors buying Selecta Biosciences stock.

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

SELB Insider Trading

Selecta Biosciences Insider Trading History Chart

Selecta Biosciences Share Price & Price History

Selecta Biosciences Insider Trading History

SEC Filings (Institutional Ownership Changes) for Selecta Biosciences (NASDAQ:SELB)

Institutional Buying and Selling by Quarter

Selecta Biosciences Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Selecta Biosciences?

Who are the major institutional investors of Selecta Biosciences?

Which major investors are selling Selecta Biosciences stock?

Which major investors are buying Selecta Biosciences stock?